Clinical Chemistry Market Growth Outlook Through 2024-2033

Overview and Scope
Clinical chemistry is a quantitative field of study that measures the concentrations of biologically significant chemicals, or analytes, in bodily fluids.

Sizing and Forecast
The clinical chemistry market size has grown strongly in recent years. It will grow from <b>$14.04 billion in 2023 to $15.02 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. </b> The growth in the historic period can be attributed to increased diagnostic testing demand, healthcare industry growth, aging population, increased disease diagnosis and management, and research and development.

The clinical chemistry market size is expected to see strong growth in the next few years. It will grow to <b>$20.06 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. </b> The growth in the forecast period can be attributed to increasing demand for precision medicine, growing need for biomarker discovery, increasing demand for personalized healthcare, emerging infectious diseases, and telemedicine and remote monitoring. Major trends in the forecast period include advanced analytical techniques, ai and machine learning integration, technological innovations, laboratory automation, and cutting-edge solutions.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/clinical-chemistry-global-market-report

Segmentation & Regional Insights
The clinical chemistry market covered in this report is segmented –

1) By Product: Analyzers, Reagents And Consumables
2) By Application: General Chemistry Test, Liver Function Test, Kidney Function Test, Urinalysis, Electrolyte Panel, Lipid Profile, Specialty Chemical Test, Other Applications
3) By End User: Hospitals, Diagnostic Or Pathology Centers, Ambulatory Surgery Centers, Other End Users

<b>North America</b> was the largest region in the chemical chemistry market in 2023. <b>Asia-Pacific</b> is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical chemistry market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7630&type=smp

Major Driver Impacting Market Growth
The increase in the prevalence of chronic diseases is expected to propel the growth of the clinical chemistry market going forward. A chronic disease is a condition that lasts for a year or longer, necessitates continuous medical care, restricts daily activities, or both. Chronic diseases, including diabetes, cancer, and heart disease, are the top causes of death and disability across the globe. Clinical chemistry creates and enhances techniques for determining the illness status and risk of a number of chronic diseases, such as cardiovascular disease, diabetes, and hormone disorders. It uses laboratory support for initiatives involving the flu and particular infectious diseases. In September 2023, the World Health Organization (WHO) reported that chronic diseases kill 41 million people each year, equivalent to 74% of all deaths globally . Therefore, the increasing prevalence of chronic diseases is driving the clinical chemistry market growth.

Key Industry Players
Major companies operating in the clinical chemistry market include <b> Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITechGroup SAS, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics Holdings plc, Diatron Mi Apac Private Limited, Nova Biomedical Corporation, Johnson & Johnson Services Inc., Alfa Wassermann USA Inc., HORIBA Ltd., Mindray Medical International Limited, Randox Laboratories Limited, SYNLAB International GmbH, Agilent Technologies Inc., Alcami Corporation, ARUP Laboratories Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Eurofins Scientific SE, GE Healthcare Technologies Ltd., Horiba Medical Inc., Laboratory Corporation, Luminex Corporation, Medtronic plc, PerkinElmer Inc., Quest Diagnostics Incorporated, Sysmex Corporation, Tosoh Corporation, Trinity Biotech plc, Waters Corporation, Werfen S.A. </b>

The clinical chemistry market report table of contents includes:

1. Executive Summary
2. Clinical ChemistryMarket Characteristics
3.Clinical Chemistry Market Trends And Strategies
4.Clinical Chemistry Market analysis
5.Clinical Chemistry Market Size And Growth
6.Clinical Chemistry Segmentation
7.Clinical Chemistry Regional And Country Analysis
.
.
.
27.Clinical Chemistry Competitive Landscape And Company Profiles
28.Clinical Chemistry Key Mergers And Acquisitions
29.Clinical Chemistry Future Outlook and Potential Analysis

TOP MAJOR PLAYERS:

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• ELITechGroup SAS
• Beckman Coulter Inc.
• Thermo Fisher Scientific Inc.

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model